Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 6.42
-0.09 (-1.38%)
Jun 1, 2026, 3:28 PM IST
Vivimed Labs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | -319.61 | -454.46 | -3,285 | -676.5 | -718.86 |
Depreciation & Amortization | 202.24 | 199.41 | 191.27 | 182.82 | 554.95 |
Asset Writedown & Restructuring Costs | - | - | 892.8 | - | - |
Other Operating Activities | 33.49 | 165.5 | 337.89 | 431.35 | 750.66 |
Change in Accounts Receivable | 87.1 | -86.64 | 105.54 | 201.39 | 1,416 |
Change in Inventory | 53.07 | 156.98 | 1,610 | 149.17 | 2,462 |
Change in Accounts Payable | -46.44 | -111.62 | 275.19 | 76.42 | -1,922 |
Change in Income Taxes | -1.78 | - | - | - | - |
Change in Other Net Operating Assets | -25.58 | -109.08 | 225.83 | -89.25 | 3,131 |
Operating Cash Flow | -17.51 | -239.91 | 353.22 | 275.4 | 5,673 |
Operating Cash Flow Growth | - | - | 28.26% | -95.14% | 612.93% |
Capital Expenditures | -45.31 | -20.39 | -49.68 | -164.1 | - |
Sale of Property, Plant & Equipment | - | - | - | - | 5,171 |
Investment in Securities | - | 303.26 | - | - | -1,131 |
Investing Cash Flow | -45.31 | 282.87 | -49.68 | -164.1 | 4,040 |
Short-Term Debt Issued | 80 | - | - | 224.56 | - |
Long-Term Debt Issued | - | - | 21.21 | 69.26 | - |
Total Debt Issued | 80 | - | 21.21 | 293.82 | - |
Short-Term Debt Repaid | - | - | - | - | -2,233 |
Long-Term Debt Repaid | -0.89 | -36 | - | - | -4,130 |
Total Debt Repaid | -0.89 | -36 | - | - | -6,362 |
Net Debt Issued (Repaid) | 79.11 | -36 | 21.21 | 293.82 | -6,362 |
Other Financing Activities | -29.47 | -24.33 | -359.03 | -397.61 | -3,791 |
Financing Cash Flow | 49.64 | -60.33 | -337.82 | -103.79 | -10,153 |
Miscellaneous Cash Flow Adjustments | - | - | 0.06 | 0.02 | -0.02 |
Net Cash Flow | -13.18 | -17.37 | -34.22 | 7.53 | -440.58 |
Free Cash Flow | -62.82 | -260.3 | 303.54 | 111.3 | 5,673 |
Free Cash Flow Growth | - | - | 172.72% | -98.04% | - |
Free Cash Flow Margin | -5.21% | -16.37% | 16.14% | 4.67% | 65.11% |
Free Cash Flow Per Share | -0.76 | -3.14 | 3.66 | 1.34 | 68.42 |
Cash Interest Paid | 29.47 | 24.32 | 359.03 | 397.6 | 538.76 |
Cash Income Tax Paid | -0.91 | 0.94 | - | - | -250.7 |
Levered Free Cash Flow | 97.2 | -254.94 | 607.08 | -134.38 | 1,973 |
Unlevered Free Cash Flow | 108.05 | -247.35 | 825.86 | 106.5 | 2,289 |
Change in Working Capital | 66.37 | -150.36 | 2,217 | 337.73 | 5,086 |